Shopping Cart
- Remove All
Your shopping cart is currently empty
Firuglipel is an orally available and selective agonist of GPR119.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 25 mg | $1,820 | 8-10 weeks | |
| 50 mg | $2,380 | 8-10 weeks | |
| 100 mg | $3,100 | 8-10 weeks |
| Description | Firuglipel is an orally available and selective agonist of GPR119. |
| In vitro | Firuglipel increases intracellular cAMP in a concentration-dependent manner in rat, human, and mouse GPR119-expressing Chinese hamster ovary (CHO)-K1 cells (EC50: 51.5, 98.4, and 108.1 nM, respectively). Firuglipel has no effect on intracellular cAMP in pcDNA3.1/CHO-K1 cells. |
| In vivo | Firuglipel (1-30 mg/kg) upregulates glucagon-like peptide-1. It also enhances glucose-dependent insulin secretion and improves glucose homeostasis in type 2 diabetic rats. |
| Molecular Weight | 467.49 |
| Formula | C25H26FN3O5 |
| Cas No. | 1371591-51-3 |
| Relative Density. | 1.31g/cm3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.